Search research articles
Contact Us
Filters
Showing results (51-60 of 60) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 60 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol
F Meric-Bernstam, L Brusco, M Daniels, et al.
ESMO Open
|
March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
T Cascone, R L Sacks, I M Subbiah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
C B Westphalen, D Martins-Branco, J R Beal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2023
HER2-low expression in patients with advanced or metastatic solid tumors
B Uzunparmak, C Haymaker, G Raso, et al.
ESMO Open
|
September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
E E Dumbrava, S G Call, H J Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2018
Selective RET kinase inhibition for patients with RET-altered cancers
V Subbiah, V Velcheti, B B Tuch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction
F Janku, H J Huang, T Fujii, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2025
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice
C B Westphalen, L Boscolo Bielo, P Aftimos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2022
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
F Griesinger, G Curigliano, M Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2018
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
L Liu, J M Toung, A F Jassowicz, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 60) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 60 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol
F Meric-Bernstam, L Brusco, M Daniels, et al.
ESMO Open
|
March 15, 2021
Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study
T Cascone, R L Sacks, I M Subbiah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development
C B Westphalen, D Martins-Branco, J R Beal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 24, 2023
HER2-low expression in patients with advanced or metastatic solid tumors
B Uzunparmak, C Haymaker, G Raso, et al.
ESMO Open
|
September 3, 2021
PIK3CA mutations in plasma circulating tumor DNA predict survival and treatment outcomes in patients with advanced cancers
E E Dumbrava, S G Call, H J Huang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2018
Selective RET kinase inhibition for patients with RET-altered cancers
V Subbiah, V Velcheti, B B Tuch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Multiplex KRASG12/G13 mutation testing of unamplified cell-free DNA from the plasma of patients with advanced cancers using droplet digital polymerase chain reaction
F Janku, H J Huang, T Fujii, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 7, 2025
ESMO Precision Oncology Working Group recommendations on the structure and quality indicators for molecular tumour boards in clinical practice
C B Westphalen, L Boscolo Bielo, P Aftimos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2022
Safety and efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer including as first-line therapy: update from the ARROW trial
F Griesinger, G Curigliano, M Thomas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2018
Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification
L Liu, J M Toung, A F Jassowicz, et al.
Page
of 6